Telephone
61.3.9215.9215
Address
Level 6 2125 Dandenong Road Clayton, Victoria (VIC) 3168
Description
Sigma Healthcare Ltd. engages in the manufacture and distribution of pharmaceutical products through pharmacy, grocery channels, and private labels. The firm's activities include wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies, including the provision of retail support services to the branded network of pharmacy members, dose administration aid services, technology and data analytics solutions to the customers. The company was founded on 2nd July, 1999 and is headquartered in Clayton, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 1.31 - 3.32
Trade Value (12mth)
AU$18,329,800.00
1 week
-0.66%
1 month
5.63%
YTD
11.94%
1 year
118.18%
All time high
3.32
EPS 3 yr Growth
-812.70%
EBITDA Margin
13.80%
Operating Cashflow
$599m
Free Cash Flow Return
0.00%
ROIC
0.00%
Interest Coverage
9.00
Quick Ratio
1.10
Shares on Issue (Fully Dilluted)
1575m
HALO Sector
Healthcare
Next Company Report Date
24-Mar-27
Ex Dividend Date (est.)
02-Sep-25
Next Dividend Pay Date (est.)
18-Sep-25
Reporting Currency
AUD
Short Sell (% of issue)
0.03
Date | Announcements |
---|---|
01 September 25 |
Change in substantial holding
×
Change in substantial holding |
01 September 25 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
27 August 25 |
Appendix 4E & Full Year Financial Report
×
Appendix 4E & Full Year Financial Report |
27 August 25 |
Sigma Full Year FY25 ASX Release
×
Sigma Full Year FY25 ASX Release |
27 August 25 |
Sigma Full Year FY25 Results Presentation
×
Sigma Full Year FY25 Results Presentation |
27 August 25 |
Management Succession
×
Management Succession |
27 August 25 |
Dividend/Distribution - SIG
×
Dividend/Distribution - SIG |
20 August 25 |
Sigma 2025 AGM
×
Sigma 2025 AGM |
20 August 25 |
Release of Shares from voluntary escrow
×
Release of Shares from voluntary escrow |
12 August 25 |
Correction to Appendix 3X
×
Correction to Appendix 3X |
04 August 25 |
Sigma FY25 Results Information
×
Sigma FY25 Results Information |
15 July 25 |
FY25 Results announcement and AGM dates
×
FY25 Results announcement and AGM dates |
17 June 25 |
Change of Auditor
×
Change of Auditor |
30 May 25 |
Appendix 3Y Change of Director's Interest Notice
×
Appendix 3Y Change of Director's Interest Notice |
27 May 25 |
Notification of cessation of securities - SIG
×
Notification of cessation of securities - SIG |
15 May 25 |
Appendix 3Y Change of Director's Interest Notice
×
Appendix 3Y Change of Director's Interest Notice |
15 May 25 |
Sigma pre-merger finalisation reports
×
Sigma pre-merger finalisation reports |
15 May 25 |
Annual Report to Shareholders
×
Annual Report to Shareholders |
15 May 25 |
Corporate Governance Statement
×
Corporate Governance Statement |
15 May 25 |
Appendix 4G
×
Appendix 4G |
15 May 25 |
Sustainability Report
×
Sustainability Report |
06 May 25 |
Trading Update
×
Trading Update |
06 May 25 |
Macquarie Sydney Conference Presentation
×
Macquarie Sydney Conference Presentation |
16 April 25 |
Appendix 3Y Change of Director's Interest Notice
×
Appendix 3Y Change of Director's Interest Notice |
25 March 25 |
Sigma AGM Extension
×
Sigma AGM Extension |
21 March 25 |
Additional Clarifying Information - Appendix 4E
×
Additional Clarifying Information - Appendix 4E |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.